Article info

Original article
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon

Authors

  1. Correspondence to Dr David Boone, Departments of Microbiology and Immunology, Indiana University School of Medicine, 1234 N. Notre Dame Ave., South Bend, IN 46617, USA; daboone{at}iu.edu
View Full Text

Citation

Grimm WA, Messer JS, Murphy SF, et al
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon

Publication history

  • Received October 29, 2014
  • Revised December 8, 2014
  • Accepted December 11, 2014
  • First published February 2, 2015.
Online issue publication 
October 26, 2017

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.